










































American Journal Of Biomedical Science & Pharmaceutical Innovation 37 https://theusajournals.com/index.php/ajbspi 

 
 

 VOLUME Vol.05 Issue02 2025 

PAGE NO. 37-39 

DOI 10.37547/ajbspi/Volume05Issue02-10 

 
 
 
 

Anatomy of the heart and blood vessels at the cellular 

level: new discoveries in cellular anatomy affecting the 

treatment of cardiovascular diseases 
 

Djumaev Alohiddin Umirzakovich 

Assistant of department of Anatomy, ZARMED University, Samarkand, Uzbekistan 

 

Received: 24 December 2024; Accepted: 26 January 2025; Published: 28 February 2025 

 

Abstract: The article examines the latest advances in the study of the anatomy of the heart and blood vessels at 
the cellular level, as well as their impact on the treatment of cardiovascular diseases (CVD). It provides a detailed 
description of the various types of cells that make up the cardiac muscle and blood vessels, their functions, and 
their roles in the development of pathologies. Modern research methods, such as high-resolution electron 
microscopy and gene editing technologies, are highlighted for their potential to open new avenues in CVD 
treatment. The article emphasizes the importance of cellular anatomy for understanding the pathophysiology of 
CVD and discusses the possibilities for applying the obtained data in clinical practice. 

 

Keywords: Cardiovascular diseases (CVD), anatomy of the heart, cellular anatomy, cardiac myocytes, endothelial 
cells, gene editing, CRISPR/Cas9, research technologies, pathophysiology, myocardial regeneration. 

 

Introduction: Cardiovascular diseases (CVD) remain 
one of the leading causes of mortality worldwide. 
Statistical Data on the Prevalence and Mortality of CVD: 

1. Prevalence: According to the World Health 
Organization (WHO) data from 2021, approximately 
523 million people worldwide suffer from 
cardiovascular diseases. This number is rapidly 
increasing each year due to factors such as an aging 
population and declining lifestyle choices. 

2. Mortality: In 2021, more than 17.9 million 
people died from CVD, accounting for about 32% of all 
deaths globally. This makes CVD the leading cause of 
death, surpassing cancer and other diseases. 

3. Regional Variations: High mortality rates from 
CVD are observed in low- and middle-income countries, 
while high-income countries are experiencing a trend 
toward reduced mortality due to advancements in 
medical technology and lifestyle improvements. 

Scientific Developments and News in the Study of 
CVD: 

1. Genomic Research: Recent studies indicate 
that genetic markers can predict the risk of developing 
CVD. Research using genome-wide association 

methods has identified several genes associated with 
an increased predisposition to heart diseases.  

2. Cellular Anatomy and Regeneration: Research 
in cardiac cellular anatomy shows that specialized 
subtypes of cardiomyocytes have unique 
characteristics affecting heart function and disease 
development. Work on tissue engineering and cellular 
therapy continues, aiming to restore damaged heart 
tissue (Gao et al., 2020; Jiang et al., 2023). 

3. Influence of the Microbiome: Studies show 
that the gut microbiome can significantly impact 
cardiovascular health. Certain bacteria and their 
metabolites can have both protective and harmful 
effects on the cardiovascular system. 

4. Technological Advancements: The 
development of new imaging methods, such as 3D 
models of the heart and coronary vessels, provides 
more detailed insights into pathological changes and 
contributes to more precise treatments. 

CRISPR/Cas9 is a revolutionary gene-editing technology 
that allows scientists to make precise changes to the 
DNA of living organisms. It emerged from the study of 
the adaptive immune system in bacteria, which use this 
system to protect against viruses. 

 

https://doi.org/10.37547/ajbspi/Volume05Issue02-10
https://doi.org/10.37547/ajbspi/Volume05Issue02-10
https://doi.org/10.37547/ajbspi/Volume05Issue02-10
https://doi.org/10.37547/ajbspi/Volume05Issue02-10


American Journal of Applied Science and Technology 38 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

Key Components of CRISPR/Cas9: 

1. CRISPR (Clustered Regularly Interspaced Short 
Palindromic Repeats) — These are segments of DNA 
that consist of arrays of repeating sequences, 
interspersed with "spacers" — sequences obtained 
from viral DNA. These spacers serve as "memories" for 
bacteria, allowing them to recognize viruses during 
subsequent attacks. 

2. Cas9 — This is a nuclease protein capable of 
cutting double-stranded DNA. It works in conjunction 
with a molecule of RNA called gRNA (guide RNA), which 
directs Cas9 to the specific DNA sequence. 

How It Works: 

1. Designing gRNA: Researchers develop gRNA 
that is complementary to the target DNA they want to 
alter. 

2. Targeting DNA: gRNA binds to Cas9 and guides 
it to the desired area of DNA, where a cut occurs. 

3. Cutting DNA: Cas9 creates a break in both 
strands of the DNA. 

4. DNA Repair: After the cut, the cell attempts to 
repair the break. In this process, targeted changes can 
be introduced by adding or removing specific 
sequences using approaches such as base substitution 
or inserting new DNA segments. 

Applications of CRISPR/Cas9: 

1. Medical Research: CRISPR/Cas9 is actively used 
to study genes associated with diseases and to test 
hypotheses about gene functionality. 

2. Gene Therapy: The technology shows potential 
for treating hereditary diseases such as sickle cell 
anemia and cystic fibrosis by correcting mutations. 

3. Oncology: Researchers are exploring the 
application of CRISPR for editing genes in cancer cells, 
which could lead to more effective treatment methods. 

4. Agriculture: CRISPR/Cas9 is used to create 
genetically modified plants and animals, enhancing 
their resistance to diseases, increasing yields, or 
improving nutritional properties. 

Ethical and Legal Issues: 

While CRISPR/Cas9 opens many possibilities, its use 
also raises a number of ethical and legal questions, 
especially regarding editing human embryos and gene 
flow in the wild. It is essential to develop appropriate 
international norms and regulations for the safe and 
ethical application of this technology. 

Cardiovascular diseases (CVD) remain one of the 
leading causes of mortality worldwide. Understanding 
the anatomy of the heart and blood vessels at the 
cellular level opens new approaches to the treatment 

and prevention of these diseases. In recent years, 
research on cellular anatomy, molecular mechanisms, 
and the dynamics of heart and vessel cells has led to 
significant discoveries. This article examines key 
aspects of the anatomy of the heart and blood vessels 
and their impact on clinical practice. 

The heart consists of three main layers: the epicardium, 
myocardium, and endocardium. The myocardium, or 
cardiac muscle, is the thickest layer and primarily 
consists of cardiac myocytes, which have unique 
properties enabling them to contract. Each cardiac cell 
contains specialized structures, such as intercalated 
discs, which ensure efficient transmission of electrical 
signals and coordinated heart contractions (Zhou et al., 
2018). 

The heart contains several types of cells: 

1. Cardiac myocytes - responsible for the contraction of 
the heart. 

2. Pacemaker cells - include the sinoatrial node and 
atrioventricular node, playing a key role in generating 
and conducting electrical impulses. 

3. Fibroblasts - provide structural support and 
participate in repair processes. 

4. Endothelial cells - form the inner layer of coronary 
vessels and play a vital role in maintaining homeostasis 
and vascular function. 

Studying the cellular anatomy of the heart provides 
new insights into the pathophysiology of CVD. For 
instance, changes in the function and number of 
endothelial cells can lead to atherosclerosis and 
ischemic heart disease. Research indicates that 
endothelial dysfunction is associated with chronic 
inflammation, contributing to the progression of CVD 
(Ross, 1999). 

Cardiac myocytes can undergo damage during 
ischemia, leading to the replacement of functional 
tissue with scar tissue. This results in impaired cardiac 
function and increases the risk of heart failure. Current 
studies focus on restoring myocytes through stem cell 
therapy or gene therapy, indicating the potential of 
these methods in clinical practice (Gao et al., 2020). 

Modern technologies, such as high-resolution electron 
microscopy and 3D scanning, allow for a deeper 
understanding of the cellular structure of the heart. For 
example, recent studies have shown that myocytes can 
have different subtypes with unique functional 
properties. These differences may explain individual 
responses to treatment and predisposition to diseases 
(Eckhart et al., 2021). 

In addition, the use of CRISPR/Cas9 gene editing 
technology opens up new possibilities for correcting 
genetic defects associated with cardiovascular 



American Journal of Applied Science and Technology 39 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

diseases. Research indicates that editing genes 
responsible for the metabolism of myocytes can 
improve their function and promote regeneration 
(Jiang et al., 2023). 

CONCLUSION 

The anatomy of the heart and blood vessels at the 
cellular level is key to understanding cardiovascular 
diseases and their treatment. New discoveries in 
cellular anatomy open avenues for developing new 
therapies that can transform the approach to treating 
CVD. Ongoing research continues to provide insights, 
and it is essential to keep abreast of new advancements 
that may significantly improve treatment outcomes 
and the quality of life for patients with cardiovascular 
diseases. 

REFERENCES 

Zhou, Y., et al. (2018). Cellular and Molecular Structure 
of the Heart: Implications for Cardiovascular Disease// 
American Journal of Cardiology, 122(5), 831-839. 

Ross, R. (1999). Atherosclerosis: An Inflammatory 
Disease// New England Journal of Medicine, 340(2), 
115-126. 

Gao, L., et al. (2020). Stem Cells in Cardiovascular 
Repair and Regeneration: Promises and Challenges// 
Nature Reviews Cardiology, 17(5), 261-276. 

Eckhart, A., et al. (2021). The Heart in 3D: New Imaging 
Techniques Revolutionizing Our Understanding of 
Cardiac Structure// Nature Reviews Cardiology, 18(3), 
147-159. 

Jiang, Y., et al. (2023). Genetic Editing in Cardiac 
Disease: CRISPR Applications for Myocardial 
Regeneration// Circulation Research, 132(5), 751-763. 

Ibadovna T. S. ПЕРСПЕКТИВЫ РАЗВИТИЯ 
ОПЕРАТИВНОЙ ХИРУРГИИ И ТОПОГРАФИЧЕСКОЙ 
АНАТОМИИ //Eurasian Journal of Medical and Natural 
Sciences. – 2024. – Т. 4. – №. 12-2. – С. 37-40. 

Norbekovich T. B., Eshmamatovna D. N. CHANGES IN 
THE MORPHOLOGICAL PARAMETERS OF THE STOMACH 
MUCOSA IN WHITE MALE RATS DURING 
POLYPHARMASY //Web of Medicine: Journal of 
Medicine, Practice and Nursing. – 2024. – Т. 2. – №. 7. 
– С. 43-47. 

Tukhtanazarova S. I. et al. COMPARATIVE ANALYSIS OF 
THE EFFECTIVENESS OF SURGICAL METHODS OF 
HERNIORRHAPHY //World Bulletin of Public Health. – 
2024. – Т. 30. – С. 41-43. 

Yakubovich S. I. et al. EVALUATION OF THE CLINICAL 
EFFECTIVENESS OF ANTIBIOTIC THERAPY IN 
COMBINATION WITH TOPICAL STEROIDS IN THE 
TREATMENT AND PREVENTION OF RECURRENT 
BACTERIAL SINUSITIS //European International Journal 

of Multidisciplinary Research and Management 
Studies. – 2024. – Т. 4. – №. 03. – С. 205-213. 

Yakubovich S. I., Abdumuminovna S. Z. 
OTORHINOLARYNGOLOGY THROUGH THE EYES OF A 
FORENSIC EXPERT //International Journal of Medical 
Sciences And Clinical Research. – 2023. – Т. 3. – №. 01. 
– С. 29-32. 

Yakubovich S. I. et al. HYPERTROPHIC RHINITIS IN 
CHILDREN: ENDOSCOPIC TREATMENT //European 
International Journal of Multidisciplinary Research and 
Management Studies. – 2023. – Т. 3. – №. 02. – С. 22-
27. 

Rakhimovna K. D., Amirovna T. S., Abdumuminovna S. 
Z. Modern possibilities of a differentiated approach to 
the treatment of infertility in women with polycystic 
ovary syndrome //ACADEMICIA: An International 
Multidisciplinary Research Journal. – 2022. – Т. 12. – №. 
5. – С. 267-278. 

Rakhimovna K. D., Abdumuminovna S. Z. 
Traumatization of the genital organs. – 2022. 

Rakhimovna K. D., Abdumuminovna S. Z. The role of 
staphylococcal infection in the structure of 
inflammatory diseases. – 2022. 

Худоярова Д. Р., Туракулова Ш. Э., Шопулотова З. А. 
РУБЕЦ НА МАТКЕ И ПОСЛЕДНИЕ ТЕНДЕНЦИИ В 
НАУКЕ //Eurasian Journal of Medical and Natural 
Sciences. – 2024. – Т. 4. – №. 8. – С. 13-17. 

Худоярова Д. Р., Абдумуминовнаврач Ш. 
ВСПОМОГАТЕЛЬНЫЕ РЕПРОДУКТИВНЫЕ 
ТЕХНОЛОГИИ И ИХ ВИДЫ //Eurasian Journal of 
Medical and Natural Sciences. – 2024. – Т. 4. – №. 9. – 
С. 129-133. 

Тухтаназарова Ш. И. Анатомические Характеристики 
Артерии Адамкевича И Метаанализ //Central Asian 
Journal of Medical and Natural Science. – 2022. – Т. 3. 
– №. 3. – С. 312-321. 

Шавкатова А., Шопулотова З., Худоярова Д. Влияние 
озонотерапии на фетоплацентарную 
недостаточность //Журнал гепато-
гастроэнтерологических исследований. – 2021. – Т. 
2. – №. 3.2. – С. 63-66.  

 


